{"url_path":"/sec/agl/8-k/2026-06-03/item-5-07","section_key":"item-5-07","section_title":"Item 5.07 Submission of Matters to a Vote of Security Holders.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-03","source_url":"https://www.sec.gov/Archives/edgar/data/1831097/0001628280-26-040370-index.html","accession_number":"0001628280-26-040370","cik":"0001831097","ticker":"AGL","issuer_name":"agilon health, inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1831097/0001628280-26-040370-index.html","primary_entity_key":"0001831097","primary_entity_name":"agilon health, inc."},"word_count":217,"has_tables":true,"body_markdown":"Item 5.07 Submission of Matters to a Vote of Security Holders.\n\nOn June 2, 2026, agilon health, inc. (the \"Company\") held its annual meeting of stockholders (the “Annual Meeting”). Below are the final voting results.\n\nProposal No. 1 - Election of Directors\n\nThe following three individuals were elected to the Company's Board of Directors to serve as Class II directors until the Company's 2029 annual meeting of stockholders and until their successors have been duly elected and qualified.\n\nName\nVotes\n\nFor\n\nVotes\n\nAgainst\n\nVotes\n\nAbstained\n\nBroker\n\nNon-Votes\n\nDiana McKenzie11,679,958177,7607,0341,870,677\n\nKaren McLoughlin9,525,4912,332,2087,0531,870,677\n\nRonald Williams10,837,6231,019,3477,7821,870,677\n\nProposal No. 2 - Ratification of Independent Registered Public Accounting Firm\n\nThe stockholders ratified the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.\n\nVotes For\n\nVotes Against\n\nVotes Abstained\n\n13,712,3686,61616,445\n\nProposal No. 3 - Non-Binding Vote on Executive Compensation\n\nThe stockholders approved, on an advisory, non-binding basis, the compensation paid to the Company’s named executive officers.\n\nVotes For\n\nVotes Against\n\nVotes Abstained\nBroker Non-Votes\n\n11,228,258627,8708,6241,870,677\n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.\n\nagilon health, inc.\n\nDate:June 3, 2026By:\n/s/ JEFFREY SCHWANEKE\n\nJeffrey Schwaneke\n\nChief Financial Officer"}